

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 8.07146459 |
| 2 | histone H4-K12 acetylation (GO:0043983) | 7.76061121 |
| 3 | fatty acid elongation (GO:0030497) | 6.04537634 |
| 4 | sulfation (GO:0051923) | 5.58049413 |
| 5 | ribosomal small subunit assembly (GO:0000028) | 5.56579944 |
| 6 | DNA deamination (GO:0045006) | 5.35696841 |
| 7 | regulation of DNA damage checkpoint (GO:2000001) | 5.22391070 |
| 8 | ribosomal small subunit biogenesis (GO:0042274) | 4.95186584 |
| 9 | proteasome assembly (GO:0043248) | 4.93646471 |
| 10 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.91494828 |
| 11 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.89569493 |
| 12 | viral transcription (GO:0019083) | 4.80929055 |
| 13 | maturation of SSU-rRNA (GO:0030490) | 4.75476595 |
| 14 | translational termination (GO:0006415) | 4.68963464 |
| 15 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.26212445 |
| 16 | translational elongation (GO:0006414) | 4.24737167 |
| 17 | cotranslational protein targeting to membrane (GO:0006613) | 4.20536180 |
| 18 | protein targeting to ER (GO:0045047) | 4.13783457 |
| 19 | cellular response to ATP (GO:0071318) | 4.13092548 |
| 20 | pseudouridine synthesis (GO:0001522) | 4.11886070 |
| 21 | regulation of glomerulus development (GO:0090192) | 4.10392062 |
| 22 | intra-S DNA damage checkpoint (GO:0031573) | 4.07341006 |
| 23 | cell proliferation in forebrain (GO:0021846) | 4.06958519 |
| 24 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.06643306 |
| 25 | response to pheromone (GO:0019236) | 4.05789054 |
| 26 | myoblast migration (GO:0051451) | 4.03239153 |
| 27 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.03135352 |
| 28 | ribosomal large subunit biogenesis (GO:0042273) | 3.99428849 |
| 29 | protein localization to endoplasmic reticulum (GO:0070972) | 3.96363139 |
| 30 | DNA strand elongation (GO:0022616) | 3.94582024 |
| 31 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.94538287 |
| 32 | nucleobase biosynthetic process (GO:0046112) | 3.91296832 |
| 33 | purine nucleobase biosynthetic process (GO:0009113) | 3.88551123 |
| 34 | translational initiation (GO:0006413) | 3.86502200 |
| 35 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.84661661 |
| 36 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.83650009 |
| 37 | viral life cycle (GO:0019058) | 3.83516192 |
| 38 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.78519726 |
| 39 | formation of translation preinitiation complex (GO:0001731) | 3.65681574 |
| 40 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.64138751 |
| 41 | positive regulation of fatty acid oxidation (GO:0046321) | 3.62423714 |
| 42 | tryptophan catabolic process (GO:0006569) | 3.61316945 |
| 43 | indole-containing compound catabolic process (GO:0042436) | 3.61316945 |
| 44 | indolalkylamine catabolic process (GO:0046218) | 3.61316945 |
| 45 | gamma-aminobutyric acid transport (GO:0015812) | 3.60353805 |
| 46 | cellular protein complex disassembly (GO:0043624) | 3.59378552 |
| 47 | serotonin metabolic process (GO:0042428) | 3.58779680 |
| 48 | DNA replication initiation (GO:0006270) | 3.55286811 |
| 49 | translation (GO:0006412) | 3.54289163 |
| 50 | regulation of hippo signaling (GO:0035330) | 3.53878214 |
| 51 | negative regulation of ligase activity (GO:0051352) | 3.53575154 |
| 52 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.53575154 |
| 53 | cullin deneddylation (GO:0010388) | 3.52515597 |
| 54 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.50542988 |
| 55 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.47523276 |
| 56 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.47523276 |
| 57 | microglial cell activation (GO:0001774) | 3.47296179 |
| 58 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.47094883 |
| 59 | kynurenine metabolic process (GO:0070189) | 3.45755139 |
| 60 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.44053523 |
| 61 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.44018211 |
| 62 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.44018211 |
| 63 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.44018211 |
| 64 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.43762397 |
| 65 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.43762397 |
| 66 | membrane tubulation (GO:0097320) | 3.43116899 |
| 67 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.42795521 |
| 68 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.42795521 |
| 69 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.42312382 |
| 70 | termination of RNA polymerase III transcription (GO:0006386) | 3.42312382 |
| 71 | regulation of collateral sprouting (GO:0048670) | 3.41727443 |
| 72 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.39165547 |
| 73 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.39103039 |
| 74 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.38953159 |
| 75 | establishment of integrated proviral latency (GO:0075713) | 3.37421297 |
| 76 | telomere maintenance via recombination (GO:0000722) | 3.36327023 |
| 77 | positive regulation of cell cycle G2/M phase transition (GO:1902751) | 3.33083651 |
| 78 | positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) | 3.33083651 |
| 79 | autophagic vacuole fusion (GO:0000046) | 3.32128222 |
| 80 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.31957292 |
| 81 | rRNA processing (GO:0006364) | 3.30345200 |
| 82 | protein deneddylation (GO:0000338) | 3.29146937 |
| 83 | fucose catabolic process (GO:0019317) | 3.28985275 |
| 84 | L-fucose metabolic process (GO:0042354) | 3.28985275 |
| 85 | L-fucose catabolic process (GO:0042355) | 3.28985275 |
| 86 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.28037672 |
| 87 | primary amino compound metabolic process (GO:1901160) | 3.26418415 |
| 88 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.25111812 |
| 89 | otic vesicle formation (GO:0030916) | 3.25062085 |
| 90 | protein polyglutamylation (GO:0018095) | 3.23437834 |
| 91 | indolalkylamine metabolic process (GO:0006586) | 3.22803978 |
| 92 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 3.21682759 |
| 93 | flavonoid metabolic process (GO:0009812) | 3.21609750 |
| 94 | protein complex disassembly (GO:0043241) | 3.21257915 |
| 95 | pyrimidine nucleoside salvage (GO:0043097) | 3.20624383 |
| 96 | pyrimidine-containing compound salvage (GO:0008655) | 3.20624383 |
| 97 | indole-containing compound metabolic process (GO:0042430) | 3.20055953 |
| 98 | nucleoside salvage (GO:0043174) | 3.19378097 |
| 99 | spliceosomal snRNP assembly (GO:0000387) | 3.19361280 |
| 100 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.18966068 |
| 101 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.16678267 |
| 102 | cornea development in camera-type eye (GO:0061303) | 3.16675908 |
| 103 | rRNA metabolic process (GO:0016072) | 3.16339750 |
| 104 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.15978558 |
| 105 | L-methionine salvage (GO:0071267) | 3.15013916 |
| 106 | L-methionine biosynthetic process (GO:0071265) | 3.15013916 |
| 107 | amino acid salvage (GO:0043102) | 3.15013916 |
| 108 | spliceosomal complex assembly (GO:0000245) | 3.14237557 |
| 109 | ncRNA 3-end processing (GO:0043628) | 3.13992314 |
| 110 | DNA damage response, detection of DNA damage (GO:0042769) | 3.12848658 |
| 111 | ribosome biogenesis (GO:0042254) | 3.12303279 |
| 112 | IMP biosynthetic process (GO:0006188) | 3.12007944 |
| 113 | cellular component biogenesis (GO:0044085) | 3.10896139 |
| 114 | telomere maintenance via telomere lengthening (GO:0010833) | 3.09870989 |
| 115 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.09652109 |
| 116 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.09490969 |
| 117 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.09490969 |
| 118 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.08263557 |
| 119 | mitotic recombination (GO:0006312) | 3.07333834 |
| 120 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.06866146 |
| 121 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.06849766 |
| 122 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.05129618 |
| 123 | regulation of DNA endoreduplication (GO:0032875) | 3.04713048 |
| 124 | macromolecular complex disassembly (GO:0032984) | 3.04502445 |
| 125 | inner cell mass cell proliferation (GO:0001833) | 3.02359462 |
| 126 | GPI anchor metabolic process (GO:0006505) | 3.00767019 |
| 127 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.00114358 |
| 128 | heart trabecula morphogenesis (GO:0061384) | 3.00061144 |
| 129 | metallo-sulfur cluster assembly (GO:0031163) | 2.99880807 |
| 130 | iron-sulfur cluster assembly (GO:0016226) | 2.99880807 |
| 131 | pharyngeal system development (GO:0060037) | 2.98872386 |
| 132 | tryptophan metabolic process (GO:0006568) | 2.98094473 |
| 133 | macrophage chemotaxis (GO:0048246) | 2.97868588 |
| 134 | establishment of viral latency (GO:0019043) | 2.97126383 |
| 135 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.97078108 |
| 136 | negative regulation of telomere maintenance (GO:0032205) | 2.96480318 |
| 137 | mRNA catabolic process (GO:0006402) | 2.96364791 |
| 138 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.94851398 |
| 139 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.93643435 |
| 140 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.93420888 |
| 141 | DNA unwinding involved in DNA replication (GO:0006268) | 2.91473101 |
| 142 | regulation of female receptivity (GO:0045924) | 2.91321614 |
| 143 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.90470921 |
| 144 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.88463596 |
| 145 | skeletal muscle tissue regeneration (GO:0043403) | 2.87887053 |
| 146 | positive regulation of ligase activity (GO:0051351) | 2.87295270 |
| 147 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.87200112 |
| 148 | cellular anion homeostasis (GO:0030002) | 2.86264524 |
| 149 | regulation of mesoderm development (GO:2000380) | 2.85076148 |
| 150 | positive regulation of cell cycle arrest (GO:0071158) | 2.84950235 |
| 151 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.84383388 |
| 152 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.84171935 |
| 153 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.84171935 |
| 154 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.84076957 |
| 155 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.83633603 |
| 156 | RNA catabolic process (GO:0006401) | 2.82531254 |
| 157 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.81486564 |
| 158 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 2.81466912 |
| 159 | respiratory chain complex IV assembly (GO:0008535) | 2.80595206 |
| 160 | regulation of G2/M transition of mitotic cell cycle (GO:0010389) | 2.80319512 |
| 161 | 7-methylguanosine mRNA capping (GO:0006370) | 2.80158246 |
| 162 | ribosome assembly (GO:0042255) | 2.79132784 |
| 163 | neuronal action potential (GO:0019228) | 2.79001007 |
| 164 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.78568327 |
| 165 | positive regulation of skeletal muscle tissue development (GO:0048643) | 2.76555579 |
| 166 | viral mRNA export from host cell nucleus (GO:0046784) | 2.76057911 |
| 167 | regulation of mitochondrial translation (GO:0070129) | 2.75229981 |
| 168 | organelle membrane fusion (GO:0090174) | 2.75058312 |
| 169 | response to nitrosative stress (GO:0051409) | 2.73998967 |
| 170 | rhodopsin mediated signaling pathway (GO:0016056) | 2.73711811 |
| 171 | vitamin biosynthetic process (GO:0009110) | 2.73487900 |
| 172 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.73213222 |
| 173 | ncRNA processing (GO:0034470) | 2.72999811 |
| 174 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.71292798 |
| 175 | ATP synthesis coupled proton transport (GO:0015986) | 2.71292798 |
| 176 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.69651445 |
| 177 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.69651445 |
| 178 | NADH dehydrogenase complex assembly (GO:0010257) | 2.69651445 |
| 179 | positive regulation of metanephros development (GO:0072216) | 2.69474110 |
| 180 | negative regulation by host of viral transcription (GO:0043922) | 2.68434594 |
| 181 | response to xenobiotic stimulus (GO:0009410) | 2.67964783 |
| 182 | limb bud formation (GO:0060174) | 2.67029800 |
| 183 | cellular response to gamma radiation (GO:0071480) | 2.64431505 |
| 184 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.63565262 |
| 185 | nucleoside diphosphate catabolic process (GO:0009134) | 2.63400085 |
| 186 | somite development (GO:0061053) | 2.62144019 |
| 187 | negative regulation of appetite (GO:0032099) | 2.62043642 |
| 188 | negative regulation of response to food (GO:0032096) | 2.62043642 |
| 189 | protein complex biogenesis (GO:0070271) | 2.60583339 |
| 190 | negative regulation of mast cell activation (GO:0033004) | 2.59254881 |
| 191 | regulation of cell cycle checkpoint (GO:1901976) | 2.58195987 |
| 192 | oxidative demethylation (GO:0070989) | 2.57049407 |
| 193 | parturition (GO:0007567) | 2.56331435 |
| 194 | cytidine metabolic process (GO:0046087) | 2.56320363 |
| 195 | cytidine catabolic process (GO:0006216) | 2.56320363 |
| 196 | cytidine deamination (GO:0009972) | 2.56320363 |
| 197 | protein sumoylation (GO:0016925) | 2.55125770 |
| 198 | regulation of action potential (GO:0098900) | 2.54942516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.05228916 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.02996181 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.84499843 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.84429576 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.70850034 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.54071353 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.41246842 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.39941370 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.32429403 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.28955369 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.05511152 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.96525192 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.95365828 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.84877667 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.81345887 |
| 16 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.77958656 |
| 17 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.69888434 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.64672053 |
| 19 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.56417017 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 2.54868934 |
| 21 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.52248197 |
| 22 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.48392333 |
| 23 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.47742380 |
| 24 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.47531097 |
| 25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.45936031 |
| 26 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.31111205 |
| 27 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.30475448 |
| 28 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.29196836 |
| 29 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.28042522 |
| 30 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.26579470 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.25921699 |
| 32 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.17647598 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.17559829 |
| 34 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.17506846 |
| 35 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.12869338 |
| 36 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.10144759 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 2.09924279 |
| 38 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.08916106 |
| 39 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.08084894 |
| 40 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.06925676 |
| 41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.03202496 |
| 42 | EWS_26573619_Chip-Seq_HEK293_Human | 2.02334419 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02066990 |
| 44 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.99447692 |
| 45 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.98681928 |
| 46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97525052 |
| 47 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.94934963 |
| 48 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.94026697 |
| 49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.88861177 |
| 50 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.88775615 |
| 51 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86502533 |
| 52 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.85549850 |
| 53 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.84845733 |
| 54 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.82836444 |
| 55 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.81715574 |
| 56 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.81021512 |
| 57 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.80031566 |
| 58 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.79335402 |
| 59 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.77924052 |
| 60 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.76282414 |
| 61 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.75242502 |
| 62 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.74716936 |
| 63 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.72769390 |
| 64 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.70122458 |
| 65 | P300_19829295_ChIP-Seq_ESCs_Human | 1.69607511 |
| 66 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.68384001 |
| 67 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.67623886 |
| 68 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.65462285 |
| 69 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.62927281 |
| 70 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.60868062 |
| 71 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.58957347 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58352682 |
| 73 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.56709888 |
| 74 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.54350039 |
| 75 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.54350039 |
| 76 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.52970225 |
| 77 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.51400587 |
| 78 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.51398780 |
| 79 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.50889259 |
| 80 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.50884180 |
| 81 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.49939790 |
| 82 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.48130766 |
| 83 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.46502674 |
| 84 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.45787478 |
| 85 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.43894950 |
| 86 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.43509922 |
| 87 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.42969840 |
| 88 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.40748964 |
| 89 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.39832674 |
| 90 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39408336 |
| 91 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.39114705 |
| 92 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.38047227 |
| 93 | MYC_22102868_ChIP-Seq_BL_Human | 1.37222627 |
| 94 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.35953806 |
| 95 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.34520843 |
| 96 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.33937472 |
| 97 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.33196436 |
| 98 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.33195171 |
| 99 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.33070748 |
| 100 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.33061028 |
| 101 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.32594028 |
| 102 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.32187233 |
| 103 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.31480551 |
| 104 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.31175168 |
| 105 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.29564545 |
| 106 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.29545360 |
| 107 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.28709794 |
| 108 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.26394203 |
| 109 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.26333808 |
| 110 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.26333808 |
| 111 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.25363516 |
| 112 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.24398483 |
| 113 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24244533 |
| 114 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.24172111 |
| 115 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.22829694 |
| 116 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.22759261 |
| 117 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22468426 |
| 118 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.20838921 |
| 119 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.20688028 |
| 120 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19900165 |
| 121 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19404728 |
| 122 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.19080806 |
| 123 | TCF4_23295773_ChIP-Seq_U87_Human | 1.18100765 |
| 124 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.18098113 |
| 125 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17394983 |
| 126 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.16435503 |
| 127 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.16328288 |
| 128 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.16262254 |
| 129 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.15954419 |
| 130 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.15840188 |
| 131 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.15617259 |
| 132 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.15119991 |
| 133 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14775694 |
| 134 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13195456 |
| 135 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.12551625 |
| 136 | AR_20517297_ChIP-Seq_VCAP_Human | 1.11126212 |
| 137 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.10822820 |
| 138 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.10065537 |
| 139 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09985721 |
| 140 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.09451641 |
| 141 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09027797 |
| 142 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08574264 |
| 143 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.08336255 |
| 144 | NCOR_22424771_ChIP-Seq_293T_Human | 1.07568063 |
| 145 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.07309299 |
| 146 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.07038326 |
| 147 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.07031620 |
| 148 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.06809163 |
| 149 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.06563749 |
| 150 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05913857 |
| 151 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.05910986 |
| 152 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.05441813 |
| 153 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.05427654 |
| 154 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.04669887 |
| 155 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.04644220 |
| 156 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04453487 |
| 157 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04259738 |
| 158 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.04151826 |
| 159 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04105108 |
| 160 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.03730433 |
| 161 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.03129006 |
| 162 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02797144 |
| 163 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02070409 |
| 164 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.01889990 |
| 165 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.01553492 |
| 166 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.01321336 |
| 167 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.99885446 |
| 168 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99440901 |
| 169 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.99176678 |
| 170 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.99090763 |
| 171 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.98274996 |
| 172 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98056868 |
| 173 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98056868 |
| 174 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.97978899 |
| 175 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.97715459 |
| 176 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.96643149 |
| 177 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.96515990 |
| 178 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.93922198 |
| 179 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.92293122 |
| 180 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.91577381 |
| 181 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.91445375 |
| 182 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.91275562 |
| 183 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.91112175 |
| 184 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.90587243 |
| 185 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88257486 |
| 186 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.87849569 |
| 187 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86901277 |
| 188 | MAF_26560356_Chip-Seq_TH1_Human | 0.86661167 |
| 189 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.86514927 |
| 190 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.86195635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.38828475 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 3.96193806 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.14498199 |
| 4 | MP0003077_abnormal_cell_cycle | 3.12422769 |
| 5 | MP0003763_abnormal_thymus_physiology | 3.05770000 |
| 6 | MP0003111_abnormal_nucleus_morphology | 3.02425702 |
| 7 | MP0009333_abnormal_splenocyte_physiolog | 2.91772394 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.91376421 |
| 9 | MP0008007_abnormal_cellular_replicative | 2.78614153 |
| 10 | MP0005646_abnormal_pituitary_gland | 2.74263547 |
| 11 | MP0008058_abnormal_DNA_repair | 2.69551374 |
| 12 | MP0001188_hyperpigmentation | 2.62548602 |
| 13 | MP0004885_abnormal_endolymph | 2.58278074 |
| 14 | MP0003195_calcinosis | 2.57875228 |
| 15 | MP0005671_abnormal_response_to | 2.54952567 |
| 16 | MP0008877_abnormal_DNA_methylation | 2.45411540 |
| 17 | MP0008057_abnormal_DNA_replication | 2.43093905 |
| 18 | MP0002102_abnormal_ear_morphology | 2.33914633 |
| 19 | MP0000631_abnormal_neuroendocrine_gland | 2.30283335 |
| 20 | MP0002160_abnormal_reproductive_system | 2.29138082 |
| 21 | MP0001835_abnormal_antigen_presentation | 2.24424559 |
| 22 | MP0004145_abnormal_muscle_electrophysio | 2.24186568 |
| 23 | MP0009785_altered_susceptibility_to | 2.21431125 |
| 24 | MP0005551_abnormal_eye_electrophysiolog | 2.20374654 |
| 25 | MP0001485_abnormal_pinna_reflex | 2.19950141 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 2.19164816 |
| 27 | MP0002837_dystrophic_cardiac_calcinosis | 2.17931512 |
| 28 | MP0008872_abnormal_physiological_respon | 2.17506288 |
| 29 | MP0000685_abnormal_immune_system | 2.13731699 |
| 30 | MP0002396_abnormal_hematopoietic_system | 2.12346828 |
| 31 | MP0005389_reproductive_system_phenotype | 2.08677854 |
| 32 | MP0002638_abnormal_pupillary_reflex | 2.06962900 |
| 33 | MP0004147_increased_porphyrin_level | 2.06510978 |
| 34 | MP0008932_abnormal_embryonic_tissue | 2.05567233 |
| 35 | MP0006082_CNS_inflammation | 2.02028429 |
| 36 | MP0004142_abnormal_muscle_tone | 1.99692134 |
| 37 | MP0006072_abnormal_retinal_apoptosis | 1.99690457 |
| 38 | MP0000049_abnormal_middle_ear | 1.97396643 |
| 39 | MP0002876_abnormal_thyroid_physiology | 1.96874006 |
| 40 | MP0003646_muscle_fatigue | 1.96624766 |
| 41 | MP0004134_abnormal_chest_morphology | 1.95880675 |
| 42 | MP0002398_abnormal_bone_marrow | 1.95711857 |
| 43 | MP0001800_abnormal_humoral_immune | 1.91692953 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.90382846 |
| 45 | MP0001968_abnormal_touch/_nociception | 1.85612157 |
| 46 | MP0002722_abnormal_immune_system | 1.77770204 |
| 47 | MP0002420_abnormal_adaptive_immunity | 1.72311395 |
| 48 | MP0002405_respiratory_system_inflammati | 1.70473865 |
| 49 | MP0002723_abnormal_immune_serum | 1.69970507 |
| 50 | MP0001819_abnormal_immune_cell | 1.68535495 |
| 51 | MP0009745_abnormal_behavioral_response | 1.66570552 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.66069154 |
| 53 | MP0001919_abnormal_reproductive_system | 1.65941114 |
| 54 | MP0006292_abnormal_olfactory_placode | 1.65622462 |
| 55 | MP0002272_abnormal_nervous_system | 1.65410112 |
| 56 | MP0002452_abnormal_antigen_presenting | 1.64297949 |
| 57 | MP0010352_gastrointestinal_tract_polyps | 1.63306854 |
| 58 | MP0001790_abnormal_immune_system | 1.62062092 |
| 59 | MP0005387_immune_system_phenotype | 1.62062092 |
| 60 | MP0005025_abnormal_response_to | 1.61079326 |
| 61 | MP0000716_abnormal_immune_system | 1.59093643 |
| 62 | MP0000490_abnormal_crypts_of | 1.58512618 |
| 63 | MP0003787_abnormal_imprinting | 1.58246552 |
| 64 | MP0006054_spinal_hemorrhage | 1.57892200 |
| 65 | MP0002735_abnormal_chemical_nociception | 1.55763698 |
| 66 | MP0000750_abnormal_muscle_regeneration | 1.53273067 |
| 67 | MP0002429_abnormal_blood_cell | 1.52791754 |
| 68 | MP0006036_abnormal_mitochondrial_physio | 1.52281968 |
| 69 | MP0004130_abnormal_muscle_cell | 1.52140171 |
| 70 | MP0005058_abnormal_lysosome_morphology | 1.51443649 |
| 71 | MP0003866_abnormal_defecation | 1.50534114 |
| 72 | MP0003567_abnormal_fetal_cardiomyocyte | 1.49995569 |
| 73 | MP0002132_abnormal_respiratory_system | 1.49930315 |
| 74 | MP0005000_abnormal_immune_tolerance | 1.46707645 |
| 75 | MP0001730_embryonic_growth_arrest | 1.46696706 |
| 76 | MP0002148_abnormal_hypersensitivity_rea | 1.41317733 |
| 77 | MP0000313_abnormal_cell_death | 1.40840802 |
| 78 | MP0002277_abnormal_respiratory_mucosa | 1.38142552 |
| 79 | MP0009250_abnormal_appendicular_skeleto | 1.37961091 |
| 80 | MP0003123_paternal_imprinting | 1.37916000 |
| 81 | MP0003011_delayed_dark_adaptation | 1.37877414 |
| 82 | MP0002019_abnormal_tumor_incidence | 1.35613154 |
| 83 | MP0004808_abnormal_hematopoietic_stem | 1.33964806 |
| 84 | MP0000026_abnormal_inner_ear | 1.33473288 |
| 85 | MP0002734_abnormal_mechanical_nocicepti | 1.32565111 |
| 86 | MP0009046_muscle_twitch | 1.31519811 |
| 87 | MP0000350_abnormal_cell_proliferation | 1.30778898 |
| 88 | MP0009840_abnormal_foam_cell | 1.30412068 |
| 89 | MP0003186_abnormal_redox_activity | 1.30067258 |
| 90 | MP0003786_premature_aging | 1.28957963 |
| 91 | MP0002736_abnormal_nociception_after | 1.28104586 |
| 92 | MP0003724_increased_susceptibility_to | 1.27886832 |
| 93 | MP0001727_abnormal_embryo_implantation | 1.27108262 |
| 94 | MP0001873_stomach_inflammation | 1.24928918 |
| 95 | MP0003221_abnormal_cardiomyocyte_apopto | 1.24775407 |
| 96 | MP0008875_abnormal_xenobiotic_pharmacok | 1.24721624 |
| 97 | MP0004019_abnormal_vitamin_homeostasis | 1.24488113 |
| 98 | MP0003880_abnormal_central_pattern | 1.24409250 |
| 99 | MP0002064_seizures | 1.23289575 |
| 100 | MP0003436_decreased_susceptibility_to | 1.22317326 |
| 101 | MP0005253_abnormal_eye_physiology | 1.21557308 |
| 102 | MP0003638_abnormal_response/metabolism_ | 1.19981787 |
| 103 | MP0004133_heterotaxia | 1.19454082 |
| 104 | MP0004185_abnormal_adipocyte_glucose | 1.19348229 |
| 105 | MP0003315_abnormal_perineum_morphology | 1.18731203 |
| 106 | MP0003938_abnormal_ear_development | 1.17974537 |
| 107 | MP0002733_abnormal_thermal_nociception | 1.14038150 |
| 108 | MP0001348_abnormal_lacrimal_gland | 1.12552466 |
| 109 | MP0001697_abnormal_embryo_size | 1.09255447 |
| 110 | MP0002163_abnormal_gland_morphology | 1.08977235 |
| 111 | MP0002080_prenatal_lethality | 1.08149862 |
| 112 | MP0005195_abnormal_posterior_eye | 1.07159838 |
| 113 | MP0000613_abnormal_salivary_gland | 1.06732675 |
| 114 | MP0001970_abnormal_pain_threshold | 1.06395739 |
| 115 | MP0000465_gastrointestinal_hemorrhage | 1.05529539 |
| 116 | MP0005645_abnormal_hypothalamus_physiol | 1.04501987 |
| 117 | MP0001764_abnormal_homeostasis | 1.03090918 |
| 118 | MP0000358_abnormal_cell_content/ | 1.02699961 |
| 119 | MP0001963_abnormal_hearing_physiology | 1.02339158 |
| 120 | MP0005084_abnormal_gallbladder_morpholo | 1.01948948 |
| 121 | MP0003937_abnormal_limbs/digits/tail_de | 1.01026587 |
| 122 | MP0002938_white_spotting | 1.00762986 |
| 123 | MP0000383_abnormal_hair_follicle | 0.99800882 |
| 124 | MP0001486_abnormal_startle_reflex | 0.99792517 |
| 125 | MP0001440_abnormal_grooming_behavior | 0.99124988 |
| 126 | MP0001853_heart_inflammation | 0.98859036 |
| 127 | MP0010155_abnormal_intestine_physiology | 0.98680089 |
| 128 | MP0002653_abnormal_ependyma_morphology | 0.96170033 |
| 129 | MP0002419_abnormal_innate_immunity | 0.95878092 |
| 130 | MP0002928_abnormal_bile_duct | 0.93634942 |
| 131 | MP0005448_abnormal_energy_balance | 0.92953192 |
| 132 | MP0004264_abnormal_extraembryonic_tissu | 0.91002263 |
| 133 | MP0004043_abnormal_pH_regulation | 0.90968016 |
| 134 | MP0002184_abnormal_innervation | 0.90413431 |
| 135 | MP0005075_abnormal_melanosome_morpholog | 0.88707666 |
| 136 | MP0000015_abnormal_ear_pigmentation | 0.88480968 |
| 137 | MP0003936_abnormal_reproductive_system | 0.88301897 |
| 138 | MP0001845_abnormal_inflammatory_respons | 0.88003390 |
| 139 | MP0009780_abnormal_chondrocyte_physiolo | 0.87893966 |
| 140 | MP0001672_abnormal_embryogenesis/_devel | 0.87484751 |
| 141 | MP0005380_embryogenesis_phenotype | 0.87484751 |
| 142 | MP0000678_abnormal_parathyroid_gland | 0.87272643 |
| 143 | MP0005083_abnormal_biliary_tract | 0.85847978 |
| 144 | MP0002751_abnormal_autonomic_nervous | 0.85207188 |
| 145 | MP0003119_abnormal_digestive_system | 0.84352024 |
| 146 | MP0006035_abnormal_mitochondrial_morpho | 0.83364055 |
| 147 | MP0002752_abnormal_somatic_nervous | 0.81951186 |
| 148 | MP0003183_abnormal_peptide_metabolism | 0.81944287 |
| 149 | MP0003984_embryonic_growth_retardation | 0.81068237 |
| 150 | MP0002088_abnormal_embryonic_growth/wei | 0.80878100 |
| 151 | MP0008469_abnormal_protein_level | 0.80566868 |
| 152 | MP0010386_abnormal_urinary_bladder | 0.80247008 |
| 153 | MP0003448_altered_tumor_morphology | 0.78070175 |
| 154 | MP0001986_abnormal_taste_sensitivity | 0.77649703 |
| 155 | MP0009379_abnormal_foot_pigmentation | 0.77135817 |
| 156 | MP0000230_abnormal_systemic_arterial | 0.76678606 |
| 157 | MP0004742_abnormal_vestibular_system | 0.73774058 |
| 158 | MP0003879_abnormal_hair_cell | 0.73460166 |
| 159 | MP0005670_abnormal_white_adipose | 0.73333884 |
| 160 | MP0003283_abnormal_digestive_organ | 0.73186063 |
| 161 | MP0001145_abnormal_male_reproductive | 0.72852199 |
| 162 | MP0000858_altered_metastatic_potential | 0.72127457 |
| 163 | MP0001905_abnormal_dopamine_level | 0.71375109 |
| 164 | MP0005332_abnormal_amino_acid | 0.70410136 |
| 165 | MP0005379_endocrine/exocrine_gland_phen | 0.69992111 |
| 166 | MP0000427_abnormal_hair_cycle | 0.69515811 |
| 167 | MP0000372_irregular_coat_pigmentation | 0.69408973 |
| 168 | MP0003718_maternal_effect | 0.68044904 |
| 169 | MP0004215_abnormal_myocardial_fiber | 0.67810324 |
| 170 | MP0005464_abnormal_platelet_physiology | 0.67684677 |
| 171 | MP0000477_abnormal_intestine_morphology | 0.67255578 |
| 172 | MP0002086_abnormal_extraembryonic_tissu | 0.66591874 |
| 173 | MP0002282_abnormal_trachea_morphology | 0.66262670 |
| 174 | MP0005410_abnormal_fertilization | 0.64744043 |
| 175 | MP0002572_abnormal_emotion/affect_behav | 0.64692139 |
| 176 | MP0003635_abnormal_synaptic_transmissio | 0.64616650 |
| 177 | MP0002085_abnormal_embryonic_tissue | 0.64589343 |
| 178 | MP0010030_abnormal_orbit_morphology | 0.64150699 |
| 179 | MP0002229_neurodegeneration | 0.64076125 |
| 180 | MP0005408_hypopigmentation | 0.63858712 |
| 181 | MP0003950_abnormal_plasma_membrane | 0.62783798 |
| 182 | MP0003943_abnormal_hepatobiliary_system | 0.62673734 |
| 183 | MP0004947_skin_inflammation | 0.62126487 |
| 184 | MP0005397_hematopoietic_system_phenotyp | 0.61479168 |
| 185 | MP0001545_abnormal_hematopoietic_system | 0.61479168 |
| 186 | MP0002084_abnormal_developmental_patter | 0.61359812 |
| 187 | MP0001293_anophthalmia | 0.60911238 |
| 188 | MP0003121_genomic_imprinting | 0.60171736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebral hypomyelination (HP:0006808) | 4.71876079 |
| 2 | Reticulocytopenia (HP:0001896) | 4.51285359 |
| 3 | Aplastic anemia (HP:0001915) | 4.44021316 |
| 4 | Congenital stationary night blindness (HP:0007642) | 4.21363043 |
| 5 | Pendular nystagmus (HP:0012043) | 4.09864724 |
| 6 | Birth length less than 3rd percentile (HP:0003561) | 4.04211104 |
| 7 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.02113494 |
| 8 | Severe visual impairment (HP:0001141) | 3.92575398 |
| 9 | Pancreatic cysts (HP:0001737) | 3.83016785 |
| 10 | Pancreatic fibrosis (HP:0100732) | 3.68340559 |
| 11 | Abnormal number of erythroid precursors (HP:0012131) | 3.66901866 |
| 12 | Oral leukoplakia (HP:0002745) | 3.60680626 |
| 13 | True hermaphroditism (HP:0010459) | 3.56586794 |
| 14 | Severe combined immunodeficiency (HP:0004430) | 3.50344868 |
| 15 | Genetic anticipation (HP:0003743) | 3.49821456 |
| 16 | Hepatocellular necrosis (HP:0001404) | 3.49118556 |
| 17 | Abolished electroretinogram (ERG) (HP:0000550) | 3.41859216 |
| 18 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.35277420 |
| 19 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.35277420 |
| 20 | Macrocytic anemia (HP:0001972) | 3.33103720 |
| 21 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.28035712 |
| 22 | Hepatic necrosis (HP:0002605) | 3.26776048 |
| 23 | 3-Methylglutaconic aciduria (HP:0003535) | 3.24347544 |
| 24 | Acute necrotizing encephalopathy (HP:0006965) | 3.22598944 |
| 25 | Congenital, generalized hypertrichosis (HP:0004540) | 3.22354457 |
| 26 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.16524390 |
| 27 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.08166073 |
| 28 | Combined immunodeficiency (HP:0005387) | 3.05088588 |
| 29 | 11 pairs of ribs (HP:0000878) | 3.04380855 |
| 30 | Methylmalonic acidemia (HP:0002912) | 3.03278864 |
| 31 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.99468449 |
| 32 | Pallor (HP:0000980) | 2.98267158 |
| 33 | Multiple enchondromatosis (HP:0005701) | 2.95387151 |
| 34 | Mitochondrial inheritance (HP:0001427) | 2.94888287 |
| 35 | Progressive cerebellar ataxia (HP:0002073) | 2.94386052 |
| 36 | Panhypogammaglobulinemia (HP:0003139) | 2.93813093 |
| 37 | Nephronophthisis (HP:0000090) | 2.88379311 |
| 38 | Abnormality of midbrain morphology (HP:0002418) | 2.87840201 |
| 39 | Molar tooth sign on MRI (HP:0002419) | 2.87840201 |
| 40 | Muscle fiber atrophy (HP:0100295) | 2.87198649 |
| 41 | Decreased central vision (HP:0007663) | 2.77771939 |
| 42 | Premature graying of hair (HP:0002216) | 2.74520787 |
| 43 | Degeneration of anterior horn cells (HP:0002398) | 2.72452669 |
| 44 | Abnormality of the anterior horn cell (HP:0006802) | 2.72452669 |
| 45 | Keratoconus (HP:0000563) | 2.71839238 |
| 46 | Increased corneal curvature (HP:0100692) | 2.71839238 |
| 47 | CNS hypomyelination (HP:0003429) | 2.71689678 |
| 48 | Type I transferrin isoform profile (HP:0003642) | 2.71638377 |
| 49 | Methylmalonic aciduria (HP:0012120) | 2.69211613 |
| 50 | Increased serum lactate (HP:0002151) | 2.67533903 |
| 51 | Confusion (HP:0001289) | 2.67056629 |
| 52 | Selective tooth agenesis (HP:0001592) | 2.66253676 |
| 53 | Rough bone trabeculation (HP:0100670) | 2.65602322 |
| 54 | Large for gestational age (HP:0001520) | 2.64309288 |
| 55 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.64218522 |
| 56 | Chorioretinal atrophy (HP:0000533) | 2.60984078 |
| 57 | Pancytopenia (HP:0001876) | 2.60879991 |
| 58 | Attenuation of retinal blood vessels (HP:0007843) | 2.57463225 |
| 59 | Furrowed tongue (HP:0000221) | 2.57019910 |
| 60 | Asplenia (HP:0001746) | 2.56677232 |
| 61 | Increased CSF lactate (HP:0002490) | 2.48494069 |
| 62 | Septo-optic dysplasia (HP:0100842) | 2.44479364 |
| 63 | Acute encephalopathy (HP:0006846) | 2.43976243 |
| 64 | Microretrognathia (HP:0000308) | 2.43875501 |
| 65 | Cellular immunodeficiency (HP:0005374) | 2.42844035 |
| 66 | Hemiparesis (HP:0001269) | 2.42236117 |
| 67 | Type 2 muscle fiber atrophy (HP:0003554) | 2.41477230 |
| 68 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.41370681 |
| 69 | Agitation (HP:0000713) | 2.40784974 |
| 70 | Thrombocytosis (HP:0001894) | 2.40601602 |
| 71 | Amaurosis fugax (HP:0100576) | 2.40479117 |
| 72 | Abnormal protein glycosylation (HP:0012346) | 2.39867181 |
| 73 | Abnormal glycosylation (HP:0012345) | 2.39867181 |
| 74 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.39867181 |
| 75 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.39867181 |
| 76 | Scotoma (HP:0000575) | 2.34399848 |
| 77 | Stenosis of the external auditory canal (HP:0000402) | 2.33927568 |
| 78 | Cystic liver disease (HP:0006706) | 2.31998813 |
| 79 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.30818506 |
| 80 | Colon cancer (HP:0003003) | 2.30413214 |
| 81 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.30277625 |
| 82 | Abnormality of macrophages (HP:0004311) | 2.28637381 |
| 83 | Abnormality of the renal medulla (HP:0100957) | 2.27391699 |
| 84 | Recurrent bronchitis (HP:0002837) | 2.27296333 |
| 85 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.26980436 |
| 86 | Postnatal microcephaly (HP:0005484) | 2.26239195 |
| 87 | Congenital sensorineural hearing impairment (HP:0008527) | 2.24632972 |
| 88 | Leukodystrophy (HP:0002415) | 2.23183090 |
| 89 | Emotional lability (HP:0000712) | 2.21639575 |
| 90 | Abnormality of T cells (HP:0002843) | 2.20528163 |
| 91 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.20158709 |
| 92 | Progressive macrocephaly (HP:0004481) | 2.19905538 |
| 93 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.19415995 |
| 94 | Lymphoma (HP:0002665) | 2.19383848 |
| 95 | Abnormality of the renal cortex (HP:0011035) | 2.18506624 |
| 96 | Trismus (HP:0000211) | 2.18280874 |
| 97 | Short hallux (HP:0010109) | 2.17966005 |
| 98 | Conjunctival hamartoma (HP:0100780) | 2.17416068 |
| 99 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.17286398 |
| 100 | Increased serum ferritin (HP:0003281) | 2.17088957 |
| 101 | Hemiplegia (HP:0002301) | 2.16261701 |
| 102 | Exercise intolerance (HP:0003546) | 2.15823998 |
| 103 | Pachygyria (HP:0001302) | 2.15663098 |
| 104 | Adactyly (HP:0009776) | 2.14688062 |
| 105 | Hypoplastic pelvis (HP:0008839) | 2.13874462 |
| 106 | Respiratory failure (HP:0002878) | 2.13521119 |
| 107 | IgM deficiency (HP:0002850) | 2.13061184 |
| 108 | Gaze-evoked nystagmus (HP:0000640) | 2.11120475 |
| 109 | Hypoplasia of the uterus (HP:0000013) | 2.10353342 |
| 110 | Breast hypoplasia (HP:0003187) | 2.09827160 |
| 111 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.09783057 |
| 112 | Eczematoid dermatitis (HP:0000976) | 2.08243776 |
| 113 | IgG deficiency (HP:0004315) | 2.06874169 |
| 114 | Male pseudohermaphroditism (HP:0000037) | 2.05070026 |
| 115 | CNS demyelination (HP:0007305) | 2.04384412 |
| 116 | Small hand (HP:0200055) | 2.03476142 |
| 117 | Abnormality of the nasal septum (HP:0000419) | 2.02823458 |
| 118 | Sclerocornea (HP:0000647) | 2.02647922 |
| 119 | Exertional dyspnea (HP:0002875) | 2.01379292 |
| 120 | Porencephaly (HP:0002132) | 2.00934018 |
| 121 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.00838249 |
| 122 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.00760514 |
| 123 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.00254828 |
| 124 | Patent foramen ovale (HP:0001655) | 1.99587128 |
| 125 | Short tibia (HP:0005736) | 1.98293678 |
| 126 | Submucous cleft hard palate (HP:0000176) | 1.97512129 |
| 127 | T lymphocytopenia (HP:0005403) | 1.97051515 |
| 128 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.96541889 |
| 129 | Concave nail (HP:0001598) | 1.95946116 |
| 130 | Renal cortical cysts (HP:0000803) | 1.95772890 |
| 131 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.95452514 |
| 132 | Thyroid-stimulating hormone excess (HP:0002925) | 1.95300581 |
| 133 | Abnormality of T cell physiology (HP:0011840) | 1.95155091 |
| 134 | Overlapping toe (HP:0001845) | 1.94549403 |
| 135 | Thyroiditis (HP:0100646) | 1.94277027 |
| 136 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.93611588 |
| 137 | Meningioma (HP:0002858) | 1.93034826 |
| 138 | Proximal tubulopathy (HP:0000114) | 1.91741590 |
| 139 | Optic nerve coloboma (HP:0000588) | 1.91730141 |
| 140 | Abnormality of the renal collecting system (HP:0004742) | 1.91585388 |
| 141 | Renal Fanconi syndrome (HP:0001994) | 1.91576499 |
| 142 | Lactic acidosis (HP:0003128) | 1.90298180 |
| 143 | Curly hair (HP:0002212) | 1.89708412 |
| 144 | Recurrent viral infections (HP:0004429) | 1.89484716 |
| 145 | Poor head control (HP:0002421) | 1.89008305 |
| 146 | Abnormal trabecular bone morphology (HP:0100671) | 1.88513052 |
| 147 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.87350267 |
| 148 | Glossoptosis (HP:0000162) | 1.87304275 |
| 149 | Generalized aminoaciduria (HP:0002909) | 1.86783873 |
| 150 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.86696241 |
| 151 | Abnormality of glycolysis (HP:0004366) | 1.85361566 |
| 152 | Increased serum pyruvate (HP:0003542) | 1.85361566 |
| 153 | Hypoplasia of the thymus (HP:0000778) | 1.84216366 |
| 154 | Recurrent fungal infections (HP:0002841) | 1.82757546 |
| 155 | Epidermoid cyst (HP:0200040) | 1.82625114 |
| 156 | Morphological abnormality of the middle ear (HP:0008609) | 1.82615426 |
| 157 | Bone marrow hypocellularity (HP:0005528) | 1.82324758 |
| 158 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.82173700 |
| 159 | Goiter (HP:0000853) | 1.81884307 |
| 160 | Abnormality of T cell number (HP:0011839) | 1.81630650 |
| 161 | Abnormality of homocysteine metabolism (HP:0010919) | 1.81081789 |
| 162 | Homocystinuria (HP:0002156) | 1.81081789 |
| 163 | Nausea (HP:0002018) | 1.80436549 |
| 164 | Slender long bone (HP:0003100) | 1.79606352 |
| 165 | Hamartoma of the eye (HP:0010568) | 1.78727671 |
| 166 | Bulbous nose (HP:0000414) | 1.78541331 |
| 167 | Spastic paraparesis (HP:0002313) | 1.78134200 |
| 168 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.77750851 |
| 169 | Anencephaly (HP:0002323) | 1.77717757 |
| 170 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.76345163 |
| 171 | Short 1st metacarpal (HP:0010034) | 1.76345163 |
| 172 | Progressive neurologic deterioration (HP:0002344) | 1.76175023 |
| 173 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.76031707 |
| 174 | Abnormality of alanine metabolism (HP:0010916) | 1.76004084 |
| 175 | Hyperalaninemia (HP:0003348) | 1.76004084 |
| 176 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.76004084 |
| 177 | Reduced antithrombin III activity (HP:0001976) | 1.75497471 |
| 178 | Optic nerve hypoplasia (HP:0000609) | 1.75094240 |
| 179 | Patellar aplasia (HP:0006443) | 1.74358521 |
| 180 | Personality changes (HP:0000751) | 1.73441695 |
| 181 | Abnormality of vitamin metabolism (HP:0100508) | 1.73225087 |
| 182 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.72212199 |
| 183 | Severe muscular hypotonia (HP:0006829) | 1.72042067 |
| 184 | Abnormality of eosinophils (HP:0001879) | 1.71647678 |
| 185 | Short femoral neck (HP:0100864) | 1.71641036 |
| 186 | Hypoplasia of the radius (HP:0002984) | 1.71376282 |
| 187 | Hyperlipoproteinemia (HP:0010980) | 1.70877411 |
| 188 | Deep palmar crease (HP:0006191) | 1.70504990 |
| 189 | Neutropenia (HP:0001875) | 1.70090542 |
| 190 | Supernumerary spleens (HP:0009799) | 1.69657107 |
| 191 | Broad-based gait (HP:0002136) | 1.68906050 |
| 192 | Inability to walk (HP:0002540) | 1.67978474 |
| 193 | Abnormality of secondary sexual hair (HP:0009888) | 1.67407320 |
| 194 | Abnormality of the axillary hair (HP:0100134) | 1.67407320 |
| 195 | Abnormality of chromosome stability (HP:0003220) | 1.66568957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 6.10615704 |
| 2 | AKT3 | 5.61094532 |
| 3 | TAF1 | 5.32026326 |
| 4 | FRK | 3.74959154 |
| 5 | NME2 | 3.55791422 |
| 6 | STK16 | 3.24882143 |
| 7 | GRK1 | 3.09224515 |
| 8 | TESK2 | 2.67165451 |
| 9 | MAP4K1 | 2.58570377 |
| 10 | KDR | 2.37044132 |
| 11 | WEE1 | 2.14980823 |
| 12 | PINK1 | 2.11889861 |
| 13 | ACVR1B | 2.09660316 |
| 14 | MAP4K2 | 2.07734438 |
| 15 | ZAP70 | 2.03895605 |
| 16 | CDC7 | 1.96807073 |
| 17 | SRPK1 | 1.94588186 |
| 18 | ZAK | 1.91544167 |
| 19 | PASK | 1.90521615 |
| 20 | INSRR | 1.82600895 |
| 21 | IRAK4 | 1.81550348 |
| 22 | TXK | 1.70449926 |
| 23 | WNK3 | 1.66655804 |
| 24 | SGK2 | 1.64373599 |
| 25 | PRKD2 | 1.58157163 |
| 26 | EIF2AK3 | 1.50204042 |
| 27 | PKN2 | 1.49908364 |
| 28 | BCKDK | 1.49024750 |
| 29 | PIM2 | 1.47830005 |
| 30 | TLK1 | 1.45776613 |
| 31 | NUAK1 | 1.45735147 |
| 32 | TAOK3 | 1.40999737 |
| 33 | TGFBR1 | 1.38014325 |
| 34 | FLT3 | 1.37262674 |
| 35 | CDK19 | 1.36448617 |
| 36 | BRSK2 | 1.36076982 |
| 37 | TSSK6 | 1.33411612 |
| 38 | STK10 | 1.31184090 |
| 39 | BTK | 1.28859209 |
| 40 | PLK4 | 1.26974766 |
| 41 | EIF2AK1 | 1.26485325 |
| 42 | ADRBK2 | 1.25803056 |
| 43 | NME1 | 1.18268074 |
| 44 | TNIK | 1.14787506 |
| 45 | SGK223 | 1.14589497 |
| 46 | SGK494 | 1.14589497 |
| 47 | VRK1 | 1.14184513 |
| 48 | PAK4 | 1.11989058 |
| 49 | NEK2 | 1.07614662 |
| 50 | MAP3K12 | 1.05837903 |
| 51 | MKNK1 | 1.04311184 |
| 52 | TYK2 | 1.04044811 |
| 53 | AURKB | 1.03582408 |
| 54 | MAP2K3 | 1.01620914 |
| 55 | RPS6KA4 | 1.01270803 |
| 56 | KIT | 1.00901600 |
| 57 | CASK | 1.00786028 |
| 58 | MAP2K2 | 1.00510426 |
| 59 | CLK1 | 0.99108487 |
| 60 | MAPK13 | 0.98682503 |
| 61 | TESK1 | 0.97903338 |
| 62 | BRAF | 0.97818387 |
| 63 | PLK1 | 0.95441998 |
| 64 | MUSK | 0.95374507 |
| 65 | MAP3K8 | 0.95322138 |
| 66 | TEC | 0.95266780 |
| 67 | PRKCI | 0.94645349 |
| 68 | CDK4 | 0.94572973 |
| 69 | ATR | 0.93582153 |
| 70 | VRK2 | 0.92122305 |
| 71 | BMPR1B | 0.90884748 |
| 72 | MAPKAPK3 | 0.90796611 |
| 73 | DYRK3 | 0.89503509 |
| 74 | AURKA | 0.89270534 |
| 75 | EPHA3 | 0.89060458 |
| 76 | MAP3K11 | 0.88211893 |
| 77 | IRAK2 | 0.88204730 |
| 78 | PBK | 0.87304011 |
| 79 | PRPF4B | 0.87096682 |
| 80 | CSNK1G3 | 0.85247769 |
| 81 | LIMK1 | 0.85040966 |
| 82 | WNK4 | 0.83812476 |
| 83 | IKBKE | 0.83575412 |
| 84 | RPS6KB2 | 0.83510838 |
| 85 | IRAK1 | 0.81435449 |
| 86 | NLK | 0.80868148 |
| 87 | EPHA2 | 0.79730973 |
| 88 | TBK1 | 0.77689872 |
| 89 | MAP3K4 | 0.76987892 |
| 90 | CDK7 | 0.76499871 |
| 91 | ERBB3 | 0.75254792 |
| 92 | PAK3 | 0.74596756 |
| 93 | ADRBK1 | 0.74328652 |
| 94 | PLK2 | 0.74179756 |
| 95 | LCK | 0.73737196 |
| 96 | MAP3K10 | 0.71864553 |
| 97 | PTK2B | 0.71570058 |
| 98 | SYK | 0.71469543 |
| 99 | MAP2K6 | 0.70595716 |
| 100 | LRRK2 | 0.69567986 |
| 101 | ABL2 | 0.68281632 |
| 102 | PRKCE | 0.67996020 |
| 103 | HIPK2 | 0.67421064 |
| 104 | SGK3 | 0.67413523 |
| 105 | MST4 | 0.67343348 |
| 106 | MARK3 | 0.66831239 |
| 107 | PIM1 | 0.65688273 |
| 108 | RPS6KA5 | 0.65155535 |
| 109 | TIE1 | 0.64888301 |
| 110 | PRKCG | 0.64494178 |
| 111 | GRK7 | 0.63450312 |
| 112 | IKBKB | 0.63038234 |
| 113 | CSNK1G1 | 0.62979312 |
| 114 | PAK1 | 0.62855107 |
| 115 | JAK3 | 0.62386327 |
| 116 | DAPK2 | 0.61509174 |
| 117 | LYN | 0.59515205 |
| 118 | CSF1R | 0.58608852 |
| 119 | PTK2 | 0.58459104 |
| 120 | OXSR1 | 0.57778384 |
| 121 | CSNK2A2 | 0.57694591 |
| 122 | DYRK2 | 0.57324944 |
| 123 | ITK | 0.57212438 |
| 124 | ARAF | 0.55848556 |
| 125 | CSNK2A1 | 0.55586647 |
| 126 | ILK | 0.55361515 |
| 127 | STK4 | 0.55094855 |
| 128 | PLK3 | 0.54962986 |
| 129 | NEK1 | 0.54688942 |
| 130 | MKNK2 | 0.53889688 |
| 131 | KSR1 | 0.53126398 |
| 132 | MAP2K7 | 0.52905050 |
| 133 | CHEK2 | 0.52761459 |
| 134 | TTK | 0.50386436 |
| 135 | GRK6 | 0.50131411 |
| 136 | BRD4 | 0.50084384 |
| 137 | EIF2AK2 | 0.49027041 |
| 138 | MAPK15 | 0.48394273 |
| 139 | STK11 | 0.46852819 |
| 140 | DAPK3 | 0.46611351 |
| 141 | CSNK1A1 | 0.46577917 |
| 142 | DAPK1 | 0.46301696 |
| 143 | PRKCQ | 0.46263931 |
| 144 | CAMK2A | 0.45188963 |
| 145 | MAP2K4 | 0.45042607 |
| 146 | CSNK1G2 | 0.44090065 |
| 147 | PRKACA | 0.43694152 |
| 148 | OBSCN | 0.43151312 |
| 149 | CDK8 | 0.43007466 |
| 150 | CDK2 | 0.42123936 |
| 151 | BLK | 0.40257453 |
| 152 | CHEK1 | 0.40234291 |
| 153 | CAMK2B | 0.39976155 |
| 154 | STK39 | 0.39712191 |
| 155 | PIK3CG | 0.39215700 |
| 156 | PHKG2 | 0.37692869 |
| 157 | PHKG1 | 0.37692869 |
| 158 | CAMKK2 | 0.32813244 |
| 159 | GRK5 | 0.31168151 |
| 160 | SGK1 | 0.29064283 |
| 161 | PRKCZ | 0.27605048 |
| 162 | CHUK | 0.27544716 |
| 163 | FGFR2 | 0.27520517 |
| 164 | CSNK1E | 0.25895551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.44114528 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.08662430 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.94722758 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.41732683 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.32451483 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 3.25155427 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.88929705 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.74701970 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 2.67741230 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.51911789 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.47834186 |
| 12 | Nicotine addiction_Homo sapiens_hsa05033 | 2.43571035 |
| 13 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.32358914 |
| 14 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.25754949 |
| 15 | RNA transport_Homo sapiens_hsa03013 | 2.24247664 |
| 16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.20511451 |
| 17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.16896773 |
| 18 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.96951384 |
| 19 | Protein export_Homo sapiens_hsa03060 | 1.96303052 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.94735263 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.87405612 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.84466410 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.84266307 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.82954841 |
| 25 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.77478175 |
| 26 | RNA degradation_Homo sapiens_hsa03018 | 1.75799363 |
| 27 | Cell cycle_Homo sapiens_hsa04110 | 1.74211625 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.71346699 |
| 29 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.71218981 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.70643514 |
| 31 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.66165085 |
| 32 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.63728023 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.63205331 |
| 34 | Parkinsons disease_Homo sapiens_hsa05012 | 1.62607239 |
| 35 | Taste transduction_Homo sapiens_hsa04742 | 1.56893099 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.53286010 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.50551557 |
| 38 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.50462695 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.44790455 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.41399823 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.41195482 |
| 42 | Sulfur relay system_Homo sapiens_hsa04122 | 1.39543420 |
| 43 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.37962455 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.37941733 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.36823334 |
| 46 | Basal transcription factors_Homo sapiens_hsa03022 | 1.33277853 |
| 47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.32099809 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.31686109 |
| 49 | Purine metabolism_Homo sapiens_hsa00230 | 1.31334441 |
| 50 | Olfactory transduction_Homo sapiens_hsa04740 | 1.28477101 |
| 51 | Melanoma_Homo sapiens_hsa05218 | 1.27623928 |
| 52 | Retinol metabolism_Homo sapiens_hsa00830 | 1.25803016 |
| 53 | Huntingtons disease_Homo sapiens_hsa05016 | 1.24860234 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.24833497 |
| 55 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.23380963 |
| 56 | Morphine addiction_Homo sapiens_hsa05032 | 1.23331448 |
| 57 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.17395230 |
| 58 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.16795694 |
| 59 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.14082939 |
| 60 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.13234314 |
| 61 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.11500737 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.10753857 |
| 63 | Alzheimers disease_Homo sapiens_hsa05010 | 0.99937421 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.99311782 |
| 65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.98863384 |
| 66 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.98342428 |
| 67 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.97669312 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.96633673 |
| 69 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.94057179 |
| 70 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.93410206 |
| 71 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.92877620 |
| 72 | Circadian entrainment_Homo sapiens_hsa04713 | 0.92396897 |
| 73 | Allograft rejection_Homo sapiens_hsa05330 | 0.89575735 |
| 74 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.87504211 |
| 75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86546433 |
| 76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84824535 |
| 77 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.83498446 |
| 78 | Insulin secretion_Homo sapiens_hsa04911 | 0.82103932 |
| 79 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81552179 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81263149 |
| 81 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80641503 |
| 82 | Measles_Homo sapiens_hsa05162 | 0.76439784 |
| 83 | Legionellosis_Homo sapiens_hsa05134 | 0.75871689 |
| 84 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75809831 |
| 85 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75729492 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75500674 |
| 87 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.74741702 |
| 88 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.71217460 |
| 89 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.68683088 |
| 90 | GABAergic synapse_Homo sapiens_hsa04727 | 0.68595823 |
| 91 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.68532400 |
| 92 | Shigellosis_Homo sapiens_hsa05131 | 0.67558433 |
| 93 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.65382812 |
| 94 | Long-term depression_Homo sapiens_hsa04730 | 0.64871571 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.63992051 |
| 96 | Leishmaniasis_Homo sapiens_hsa05140 | 0.61565078 |
| 97 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61117198 |
| 98 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.60939818 |
| 99 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.60616177 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59858426 |
| 101 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57364675 |
| 102 | Viral myocarditis_Homo sapiens_hsa05416 | 0.56825080 |
| 103 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56641290 |
| 104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55302395 |
| 105 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.55164905 |
| 106 | Salivary secretion_Homo sapiens_hsa04970 | 0.54981180 |
| 107 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.54260142 |
| 108 | Carbon metabolism_Homo sapiens_hsa01200 | 0.53108713 |
| 109 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.52505135 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52462510 |
| 111 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51281732 |
| 112 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50487622 |
| 113 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.49523922 |
| 114 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49262660 |
| 115 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49261816 |
| 116 | Cocaine addiction_Homo sapiens_hsa05030 | 0.48669671 |
| 117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47730161 |
| 118 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.47032433 |
| 119 | Renin secretion_Homo sapiens_hsa04924 | 0.46585521 |
| 120 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46230826 |
| 121 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46097616 |
| 122 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.45085405 |
| 123 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.43163680 |
| 124 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42509039 |
| 125 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.42490317 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42425236 |
| 127 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42042263 |
| 128 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.41380533 |
| 129 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40306874 |
| 130 | Alcoholism_Homo sapiens_hsa05034 | 0.40199149 |
| 131 | Asthma_Homo sapiens_hsa05310 | 0.40164649 |
| 132 | Apoptosis_Homo sapiens_hsa04210 | 0.38670480 |
| 133 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37664080 |
| 134 | Pertussis_Homo sapiens_hsa05133 | 0.36521567 |
| 135 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.35668821 |
| 136 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.33744903 |
| 137 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.33701412 |
| 138 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31425368 |
| 139 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.29339583 |
| 140 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.27285455 |
| 141 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.26544014 |
| 142 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.26023356 |
| 143 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.23206343 |
| 144 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23051637 |
| 145 | Influenza A_Homo sapiens_hsa05164 | 0.21617669 |
| 146 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.21246993 |
| 147 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.19827321 |
| 148 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.17778443 |
| 149 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.17753113 |
| 150 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.17145741 |
| 151 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.16671150 |
| 152 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.16642520 |
| 153 | Hepatitis B_Homo sapiens_hsa05161 | 0.15518221 |
| 154 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.15230605 |
| 155 | Lysosome_Homo sapiens_hsa04142 | 0.14168965 |
| 156 | Peroxisome_Homo sapiens_hsa04146 | 0.13731167 |
| 157 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.13264255 |
| 158 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.13142437 |

